[go: up one dir, main page]

DE602007006634D1 - Peptidaptamer zum neutralisieren der bindung von platelet-antigen-spezifischen antikörpern und diagnostische und therapeutische anwendungen, die dieses enthalten - Google Patents

Peptidaptamer zum neutralisieren der bindung von platelet-antigen-spezifischen antikörpern und diagnostische und therapeutische anwendungen, die dieses enthalten

Info

Publication number
DE602007006634D1
DE602007006634D1 DE602007006634T DE602007006634T DE602007006634D1 DE 602007006634 D1 DE602007006634 D1 DE 602007006634D1 DE 602007006634 T DE602007006634 T DE 602007006634T DE 602007006634 T DE602007006634 T DE 602007006634T DE 602007006634 D1 DE602007006634 D1 DE 602007006634D1
Authority
DE
Germany
Prior art keywords
specific antibodies
platelet
antigen
hpa
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007006634T
Other languages
English (en)
Inventor
Dominique Rigal
Julien Thibaut
Gemain Gillet
Yves Merieux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiftung fur Diagnostische Forschung
Original Assignee
Stiftung fur Diagnostische Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiftung fur Diagnostische Forschung filed Critical Stiftung fur Diagnostische Forschung
Publication of DE602007006634D1 publication Critical patent/DE602007006634D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/222—Platelet disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE602007006634T 2006-02-07 2007-02-07 Peptidaptamer zum neutralisieren der bindung von platelet-antigen-spezifischen antikörpern und diagnostische und therapeutische anwendungen, die dieses enthalten Active DE602007006634D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06002496 2006-02-07
PCT/EP2007/001042 WO2007090630A2 (en) 2006-02-07 2007-02-07 Peptide aptamer for neutralizing the binding of platelet antigene specific antibodies and diagnostic and therapeutic applications containing the same

Publications (1)

Publication Number Publication Date
DE602007006634D1 true DE602007006634D1 (de) 2010-07-01

Family

ID=38223347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007006634T Active DE602007006634D1 (de) 2006-02-07 2007-02-07 Peptidaptamer zum neutralisieren der bindung von platelet-antigen-spezifischen antikörpern und diagnostische und therapeutische anwendungen, die dieses enthalten

Country Status (8)

Country Link
US (2) US8183055B2 (de)
EP (1) EP1987057B1 (de)
JP (1) JP5042237B2 (de)
AT (1) ATE468351T1 (de)
DE (1) DE602007006634D1 (de)
DK (1) DK1987057T3 (de)
ES (1) ES2345569T3 (de)
WO (1) WO2007090630A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0717166D0 (en) * 2007-09-04 2007-10-17 Univ Brighton Method for stabilisation of purified P-Glycoprotein
JP5210620B2 (ja) * 2007-12-19 2013-06-12 独立行政法人科学技術振興機構 ペプチドアプタマーライブラリーの作製方法および用途
KR101951968B1 (ko) 2011-03-03 2019-02-25 더 리전트 오브 더 유니버시티 오브 캘리포니아 세포 조작용 나노피펫 장치
DK2796881T3 (en) * 2013-04-26 2018-01-02 Davos Diagnostics Ag Platelet allogeneic antigen type and platelet antibody test.
MX376061B (es) 2014-03-31 2025-03-07 Rallybio Ipa Llc Anticuerpos contra antìgeno de plaqueta 1a humano (hpa-1a).
CN111175488A (zh) * 2020-03-24 2020-05-19 天津美瑞特医疗科技有限公司 一种应用流式细胞术检测血小板抗体特异性的方法及检测试剂盒
CA3181176A1 (en) * 2020-04-27 2021-11-04 CCOA Therapeutics Inc. Rapid and facile antibody detection using covalently immobilized self-assembled polypeptides
WO2025137775A1 (en) * 2023-12-29 2025-07-03 Marshall John G Method of generating and screening synthetic peptide aptamer libraries

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223390D0 (en) 1992-11-07 1992-12-23 Common Services Agency Anti-hpa1 testing

Also Published As

Publication number Publication date
WO2007090630A2 (en) 2007-08-16
US20120245338A1 (en) 2012-09-27
ATE468351T1 (de) 2010-06-15
WO2007090630A3 (en) 2007-09-20
JP5042237B2 (ja) 2012-10-03
EP1987057B1 (de) 2010-05-19
DK1987057T3 (da) 2010-08-30
JP2009525725A (ja) 2009-07-16
US8183055B2 (en) 2012-05-22
EP1987057A2 (de) 2008-11-05
ES2345569T3 (es) 2010-09-27
US20090318363A1 (en) 2009-12-24
US8563704B2 (en) 2013-10-22

Similar Documents

Publication Publication Date Title
DE602007006634D1 (de) Peptidaptamer zum neutralisieren der bindung von platelet-antigen-spezifischen antikörpern und diagnostische und therapeutische anwendungen, die dieses enthalten
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
CY1120951T1 (el) Ανθρωπινα αντισωματα enanti-tau
CL2016002624A1 (es) Anticuerpos humanos que se unen al gen 3 de activación linfocitaria (lag-3) y los usos de estos (divisional sol. n°0308-2011)
DE602004017201D1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
NZ701444A (en) Antibodies to matrix metalloproteinase 9
HUP0202532A2 (hu) Ko-stimulátor szignál-transzdukciós molekula (AILIM) elleni humán monoklonális antitest és gyógyászati alkalmazása
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
MX344935B (es) Analisis para detectar anticuerpos especificos a anticuerpos anti-ige terapeuticos y su uso en anafilaxis.
EA201291181A1 (ru) Композиции и способы применения терапевтических поливалентных антител против белка, родственного рецептору липопротеинов низкой плотности 6 (lrp6)
AR067199A1 (es) Proteinas de union a antigenos que se unen a par-2
BRPI0114343B8 (pt) método para detecção de imunoglobulina ige e para diagnóstico in vitro de alergias, bem como chip de microarranjo e kit que o compreende
ATE534667T1 (de) Anti-abeta antikörper
IN2014DN08011A (de)
JP2020516603A5 (de)
JP2016528236A5 (de)
ATE474857T1 (de) Antikörper gegen ein epitop auf agr2, assays und hybridome
ATE550354T1 (de) Humane ringspezifische bnp-antikörper
MX2020013814A (es) Ensayo multiple proteomico mejorado.
ATE401338T1 (de) Von fibrin abgeleitete citrullinpeptide, die durch für rheumatoide arthritis spezifische autoantikörper erkannt werden, und deren verwendung
EP2565647A4 (de) Reagens zum testen eines antikörpers gegen treponema pallidum
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
WO2010053772A3 (en) Disease-associated antigens and methods of use thereof
DE502006004301D1 (de) Diagnose von allergischen erkrankungen, atopischen erkrankungen und/oder autoimmunerkrankungen durch nachweis von autoantikörpern gegen cd28 in humanem serum
ATE443871T1 (de) Test zum nachweis von pathologischen prionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition